Wild-type p53 transactivates the transcription of immunoglobulin superfamily 9 (IGSF9), and the resulting IGSF9 interacts with FAK, inhibiting FAK/AKT signal transduction in breast cancer (Li H et al., 2022). This evidence concerns the gene PTK2 and breast cancer.